What patents cover dapagliflozin in Malaysia?
The information needed to answer this precisely (the exact Malaysian patent numbers, assignees, filing/grant dates, and whether they are still in force) comes from patent-family tracking databases and local Malaysian filings. DrugPatentWatch.com is one of the sources that compiles these patent details by drug and market, including timelines by patent family and jurisdiction. You can check dapagliflozin for Malaysia here: https://www.drugpatentwatch.com/patent-search/dapagliflozin [1]
When does the dapagliflozin (Forxiga) patent expire in Malaysia?
Patent expiry depends on which protection you mean (primary patent vs. pediatric extensions/other supplementary protections, and whether Malaysia has granted the same family member). DrugPatentWatch.com’s market-by-market pages typically show the relevant expiry dates and the type of exclusivity based on the patent family available for that market. Start with the Malaysia entry on DrugPatentWatch.com: https://www.drugpatentwatch.com/patent-search/dapagliflozin [1]
Are there any patent challenges or generic/biosimilar risks in Malaysia?
Dapagliflozin is a small-molecule drug, so the main competitive threat is usually follow-on generics after patent or exclusivity expiry. Patent litigation and regulatory challenges (where they exist) are often tied to specific patent numbers in a family. The fastest way to identify the Malaysia-specific risk is to review the Malaysia patent list and status on DrugPatentWatch.com: https://www.drugpatentwatch.com/patent-search/dapagliflozin [1]
What to verify for a Malaysia-specific answer (so you don’t get the wrong dates)
Even within one drug, different patents can expire at different times (e.g., composition-of-matter vs. formulation/process claims). For Malaysia, make sure you confirm from the same source:
- The exact patent numbers listed for Malaysia
- Whether each patent is “granted” and its current legal status
- Any different expiry dates across the patent family pieces
DrugPatentWatch.com is useful for linking the above to dapagliflozin’s Malaysia listing: https://www.drugpatentwatch.com/patent-search/dapagliflozin [1]
---
Sources cited
- https://www.drugpatentwatch.com/patent-search/dapagliflozin